Insulet Corporation (PODD)
NASDAQ: PODD
· Real-Time Price · USD
348.59
5.06 (1.47%)
At close: Sep 04, 2025, 2:03 PM
1.47% (1D)
| Bid | 316.25 |
| Market Cap | 24.54B |
| Revenue (ttm) | 2.36B |
| Net Income (ttm) | 236.1M |
| EPS (ttm) | 3.28 |
| PE Ratio (ttm) | 106.28 |
| Forward PE | 59.26 |
| Analyst | Buy |
| Ask | 374.37 |
| Volume | 216,824 |
| Avg. Volume (20D) | 696,343 |
| Open | 343.34 |
| Previous Close | 343.53 |
| Day's Range | 341.89 - 349.09 |
| 52-Week Range | 211.27 - 350.00 |
| Beta | 1.35 |
About PODD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PODD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PODD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Insulet Corporation is scheduled to release its earnings on
Nov 6, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 weeks ago
+9.47%
Insulet shares are trading higher after the compan...
Unlock content with
Pro Subscription
2 months ago
-4.52%
Shares of glucose monitor and insulin pump stocks are trading lower after the CMS proposed that continuous glucose monitors and insulin infusion pumps be reclassified under the frequent and substantial servicing payment category.
